Hepatitis B and Pregnancy-Virologic and Immunologic Characteristics

Changes of virological and immune response characteristics of HBV infected pregnant women during pregnancy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054116

Enrollment

Unknown

Registered

2021-12-09

Start date

2021-12-16

Completion date

Unknown

Last updated

2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis B

Interventions

Case series:None

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women with chronic hepatitis B virus infection in the Second Affiliated Hospital of Chongqing Medical University; 2. The diagnostic criteria refer to the 2019 edition of the Guidelines for the Prevention and Treatment of Chronic Hepatitis B. Pregnant women were registered at the time of card establishment at the infectious disease clinic and were followed up to 2 years postpartum.

Exclusion criteria

Exclusion criteria: Patients with other hepatotropic virus infection, human immunodeficiency virus infection, liver cirrhosis and pregnancy-related diseases, such as intrahepatic cholestasis of pregnancy, hypertensive diseases of pregnancy, etc.

Design outcomes

Primary

Measure	Time frame
pregenomic RNA;pregenomic RNA;core-associated antigen;	—

Countries

China

Contacts

Public ContactHu Peng

The Second Affiliated Hospital of Chongqing Medical University

hp_cq@163.com+86 13608338064

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026